Back to results
Active, not recruitingPhase 1

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

NCT05492682

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Krankenhaus Nordwest

Frankfurt, Germany

+2 additional locations

View on ClinicalTrials.gov
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer — TrialFind